SFE Investment Counsel Acquires Shares of 17,252 Danaher Corporation $DHR

SFE Investment Counsel acquired a new stake in shares of Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 17,252 shares of the conglomerate’s stock, valued at approximately $12,422,000. Danaher makes up approximately 1.7% of SFE Investment Counsel’s portfolio, making the stock its 20th biggest position.

Other institutional investors also recently modified their holdings of the company. State Street Corp increased its position in shares of Danaher by 1.7% during the fourth quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after acquiring an additional 472,608 shares in the last quarter. Capital International Investors lifted its position in Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after acquiring an additional 1,487,768 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in Danaher by 9.1% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock valued at $3,656,595,000 after acquiring an additional 1,334,221 shares in the last quarter. Wellington Management Group LLP boosted its stake in Danaher by 11.2% during the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock valued at $3,451,380,000 after purchasing an additional 1,517,904 shares during the last quarter. Finally, Norges Bank acquired a new position in Danaher during the 4th quarter valued at about $2,177,106,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Stifel Nicolaus lowered their price objective on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. UBS Group decreased their price target on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Citigroup assumed coverage on Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target for the company. Finally, HSBC dropped their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Price Performance

Danaher stock opened at $202.51 on Friday. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company’s 50 day moving average price is $193.14 and its two-hundred day moving average price is $193.21. The stock has a market cap of $142.37 billion, a P/E ratio of 35.97, a P/E/G ratio of 2.52 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.77 earnings per share. On average, equities analysts predict that Danaher Corporation will post 8.53 earnings per share for the current year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.